Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (19 quarters reported)
$412M in Q4 2021 → $226M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Cellebrite Di Ltd | 89.6% | Unchanged | 13,861,007 | $202M |
| Open Lending Corp | 10.4% | Unchanged | 7,545,144 | $23.5M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed July 16, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed May 06, 2026
No position changes this quarter.
quarter ended December 31, 2025 · filed January 23, 2026
No position changes this quarter.
quarter ended September 30, 2025 · filed October 23, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed July 24, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed April 30, 2025
No position changes this quarter.
quarter ended December 31, 2024 · filed February 05, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cellebrite Di Ltd | Added | +2,130,386 | +$46.9M | 87.1% |
quarter ended September 30, 2024 · filed November 13, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cellebrite Di Ltd | Trimmed | −1,656,879 | −$27.9M | 81.1% |
Loading...
